A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies

International Journal of Pharmaceutics
Fu-Qiang HuSu Zeng

Abstract

Stearic acid (SA) grafted chitosan oligosaccharide (CSO) (CSO-SA), which was synthesized by an 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)-mediated coupling reaction, was demonstrated to form micelle like structure by self-aggregation in aqueous solution. The critical micelle concentration (CMC) of CSO-SA with 15.4% amino substituted degree of CSO was about 0.035 mg/ml. The micelles with 1mg/ml CSO-SA concentration had 70.6 nm volume average hydrodynamic diameter with a narrow size distribution and 46.4+/-0.1 mV surface potential. Due to the cationic property, the micelles could compact the plasmid DNA to form micelle/DNA complexes nanoparticles, which can efficiently protect the condensed DNA from enzymatic degradation by DNase I. The volume average hydrodynamic diameter of CSO-SA micelle/DNA complex increased from 203 nm to 318 nm and decreased to 102 nm due to the variation of zeta potential when the N/P ratio increased from 0.25 to 3.6 and from 3.6 to 58. The IC(50) value of the CSO-SA micelle against A549 cells was 543.16 microg/ml, while the IC(50) of Lipofectamine 2000 was about 6 microg/ml. The in vitro transfection efficiency of CSO-SA micelles was investigated by using plasmid DNA (pEGFP-C1). The transfection ...Continue Reading

References

Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·A Bernkop-Schnürch, M E Krajicek
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·K Y LeeS Y Jeong
Jun 27, 2000·International Journal of Pharmaceutics·Q ZhangT Nagai
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·Z Cui, R J Mumper
Aug 22, 2001·Biochimica Et Biophysica Acta·T IshiiT Sato
Aug 23, 2001·Advanced Drug Delivery Reviews·L IllumS S Davis
Nov 24, 2001·Advanced Drug Delivery Reviews·G Borchard
Jul 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ji Hoon Jeong, Tae Gwan Park
Apr 26, 2003·Science·Radoslav SavicDusica Maysinger
Sep 13, 2003·Nature Materials·Aliasger K SalemKam W Leong
Jan 20, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sania MansouriJulio C Fernandes
Jan 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Su Young ChaeJae-Woon Nah
Feb 16, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hyuk Sang YooSeo Young Jeong
Apr 12, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Thomas KeanMaya Thanou
May 12, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Han Chang KangYou Han Bae
May 17, 2005·Nature Materials·Hyun Joon KongDavid J Mooney
Jun 14, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Karen SellinsSteven Dow

❮ Previous
Next ❯

Citations

Aug 15, 2009·Journal of Materials Science. Materials in Medicine·Dunwan ZhuXigang Leng
Dec 3, 2010·Nanoscale Research Letters·Min ZhangShi-Wen Huang
Mar 30, 2010·Acta Pharmacologica Sinica·Jian LiYun-feng Wang
Aug 17, 2011·International Journal of Nanomedicine·Yong-Zhong DuFu-Qiang Hu
Jul 18, 2012·International Journal of Nanomedicine·Yi-Ting XieFu-Qiang Hu
Oct 12, 2012·International Journal of Nanomedicine·Hong YuanFu-Qiang Hu
Nov 26, 2008·Nanomedicine·Maria de la FuenteMaria Jose Alonso
Jun 28, 2014·International Journal of Nanomedicine·Jing-Jing YaoFu-Qiang Hu
Jul 30, 2009·Expert Opinion on Drug Delivery·Yoshie Maitani, Yoshiyuki Hattori
Feb 16, 2016·International Journal of Pharmaceutics·Elena Fernández FernándezFrancisco M Goycoolea
Jun 20, 2008·Journal of Pharmaceutical Sciences·Yi-Qing YeHe-Yong Yu
Dec 26, 2015·Molecular Pharmaceutics·Pedro M D MorenoAna Paula Pêgo
Jan 24, 2012·International Journal of Pharmaceutics·Xiaoli SunNa Zhang
Aug 24, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Qian LiFu-Qiang Hu
Jul 16, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Fu-Qiang HuHong Yuan
May 20, 2008·Advanced Drug Delivery Reviews·Ghaleb A Husseini, William G Pitt
Jan 22, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joohee JungShun'ichi Kuroda
Dec 22, 2007·International Journal of Pharmaceutics·Yi-Qing YeHe-Yong Yu
Nov 13, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Fu-Qiang HuHong Yuan
Apr 12, 2008·Journal of Biomedical Materials Research. Part a·Yu-Lun LouKam W Leong
Mar 8, 2013·International Journal of Pharmaceutics·Buddhadev Layek, Jagdish Singh
Aug 12, 2014·Biotechnology Advances·Yu YangMeiwan Chen
Jun 20, 2012·Carbohydrate Polymers·Buddhadev Layek, Jagdish Singh
Jul 16, 2015·Human Gene Therapy·Ling LiYu-Quan Wei

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.